{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:04:36Z","timestamp":1790053476182,"version":"4.0.1"},"reference-count":9,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Lichen amyloidosis (LA) is an intractable, chronic pruritic skin disorder characterized by amyloid deposition within the dermal papillae. It manifests as severely itchy, hyperpigmented papules and cobblestone plaques mainly distributed on the extremities. Conventional treatment modalities often yield partial or temporary therapeutic effects with unstable efficacy. This paper describes the case of a 60-year-old Chinese male patient presenting with a 3-year history of progressive, refractory lichen amyloidosis involving bilateral limbs. Over a 2-year period, the patient had failed multiple successive and combined treatment regimens, including oral antihistamines and potent topical glucocorticoids, while histopathological staining results confirmed primary localized cutaneous amyloidosis. After monotherapy with 15\u2005mg oral upadacitinib once daily, the patient achieved rapid remission: pruritus was greatly relieved within 1\u2005month, with the numerical rating score dropping from 8 to 1\u20132; this improvement was accompanied by obvious flattening of the papules, a decrease in lesion quantity, fading of pigmentation, and the disappearance of cobblestone skin lesions. No short-term adverse reactions were observed during medication. This case adds new clinical evidence supporting the therapeutic value of JAK1 inhibitors in the management of refractory inflammatory dermatoses, confirms the key involvement of IL-31-dependent JAK1 signaling in the pathogenesis of LA, and highlights upadacitinib as a promising rescue regimen for conventional treatment-resistant lichen amyloidosis, offering clinicians a clinical reference for employing JAK1-targeted therapy to disrupt the pathological itch\u2013scratch cycle. Nonetheless, larger prospective cohort studies and randomized controlled trials are still required to validate the long-term efficacy, optimal dosage, and safety profile of upadacitinib in patients with lichen amyloidosis.<\/jats:p>","DOI":"10.3389\/fmed.2026.1932492","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:23:58Z","timestamp":1790051038000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Rapid therapeutic response in refractory lichen amyloidosis treated with upadacitinib: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Teng","sequence":"first","affiliation":[{"name":"Center for Plastic and Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[{"name":"Center for Plastic and Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, People's Hospital of Tiantai County, Taizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Gao","sequence":"additional","affiliation":[{"name":"Center for Plastic and Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ding","sequence":"additional","affiliation":[{"name":"Center for Plastic and Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gairong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tongxiang First People's Hospital, Tongxiang, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1111\/ajd.14012","article-title":"Primary cutaneous amyloidosis: a review of the available studies and gaps in data","volume":"64","author":"Aung","year":"2023","journal-title":"Australas J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40257-017-0278-9","article-title":"Primary localized cutaneous amyloidosis: a systematic treatment review","volume":"18","author":"Weidner","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e13899","DOI":"10.1111\/cts.13899","article-title":"Dupilumab: mechanism of action, clinical, and translational science","volume":"17","author":"McCann","year":"2024","journal-title":"Clin Transl Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.18176\/jiaci.0682","article-title":"Dupilumab: a review of present indications and off-label uses","volume":"32","author":"Mu\u00f1oz-Bellido","year":"2022","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jdcr.2025.06.061","article-title":"Remission of lichen amyloidosis achieved with upadacitinib: a case report","volume":"65","author":"Ziebart","year":"2025","journal-title":"JAAD Case Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1365-2133.2009.09311.x","article-title":"New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis","volume":"161","author":"Tanaka","year":"2009","journal-title":"Br J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1111\/jdv.18756","article-title":"Upadacitinib for treatment-resistant lichen amyloidosis","volume":"37","author":"Solimani","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e70146","DOI":"10.1002\/kjm2.70146","article-title":"Refractory lichen amyloidosis coexisting with atopic dermatitis responsive to sequential Janus kinase inhibitor therapy: upadacitinib followed by abrocitinib","volume":"42","author":"Tsai","year":"2026","journal-title":"Kaohsiung J Med Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.23736\/S2784-8671.24.07895-2","article-title":"Anti-herpes zoster vaccination in patients with dermatologic diseases: a position statement from the Italian SIDeMaST group of sexually transmitted, infectious and tropical diseases","volume":"159","author":"Ciccarese","year":"2024","journal-title":"Ital J Dermatol Venerol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1932492\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:23:59Z","timestamp":1790051039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1932492\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":9,"alternative-id":["10.3389\/fmed.2026.1932492"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1932492","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1932492"}}